Theriva Biologics, Inc. Payments to Employees
Theriva Biologics, Inc. (TOVX) had Payments to Employees of $667.54 thousand as of 2024-12-13, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToEmployees · last filed 2025-03-06
- 2024-12-13: Payments to Employees $667.54K.
- 2023-12-14: Payments to Employees $644.96K.
- 2022-12-15: Payments to Employees $614.25K.
| Period end | Payments to Employees |
|---|---|
| 2024-12-13 | $667.54K 10-K · filed 2025-03-06 |
| 2023-12-14 | $644.96K 10-K · filed 2025-03-06 |
| 2022-12-15 | $614.25K 10-K · filed 2025-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |